PATRICIA POWELL: Open Payments
NPI 1528452265 · DOVER, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 36 payments from 9 companies in 2025. Trend: 2023 $892 · 2024 $867 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $228 |
| AstraZeneca Pharmaceuticals LP | 1 | $98 |
| Orexo US, Inc. | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Lilly USA, LLC | 1 | $21 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $14 |
Products named: UBRELVY, QULIPTA, AIRSUPRA, REXULTI, Zubsolv, CAPLYTA, MOUNJARO, VOQUEZNA.
Industry payments across DE — which companies pay providers there.
